Cannon Global Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,500	Closed	-$90.3K	–	70
2025 Q1	$90.3K	Buy	+25,500	New	+$90.3K	0.16%	69